Barclays PLC Applied Genetic Technologies Corp Transaction History

Barclays PLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.87 - $2.91 $10,453 - $16,266	-5,590 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$3.01 - $4.12 $12,371 - $16,933	-4,110 Reduced 42.37%	5,590 $17,000
Q2 2021 Aug 13, 2021	SELL	$3.62 - $5.23 $94,554 - $136,607	-26,120 Reduced 72.92%	9,700 $38,000
Q1 2021 May 13, 2021	BUY	$3.94 - $8.19 $37,299 - $77,534	9,467 Added 35.92%	35,820 $182,000
Q4 2020 Feb 11, 2021	SELL	$3.99 - $5.7 $23,034 - $32,906	-5,773 Reduced 17.97%	26,353 $108,000
Q3 2020 Nov 12, 2020	SELL	$4.38 - $6.43 $18,067 - $26,523	-4,125 Reduced 11.38%	32,126 $156,000
Q2 2020 Aug 12, 2020	BUY	$3.0 - $6.9 $108,753 - $250,131	36,251 New	36,251 $201,000
Q1 2020 May 13, 2020	SELL	$2.36 - $9.86 $16 - $69	-7 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$2.69 - $4.92 $18 - $34	7 New	7 $0
Q2 2019 Aug 14, 2019	SELL	$3.6 - $4.78 $302 - $401	-84 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$3.4 - $4.15 $35,360 - $43,160	-10,400 Reduced 99.2%	84 $0
Q3 2017 Nov 14, 2017	BUY	$3.55 - $5.25 $37,218 - $55,041	10,484	10,484 $41,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.